BostonGene leverages AI-integrated molecular analytics and biomarker discovery to match therapies for cancer and immune-related diseases, improving patient outcomes. Their multi-omic approach and concierge-service model provide customized, data-driven solutions for optimizing standard-of-care therapies and accelerating research.
